While clinical remote monitoring, artificial intelligence (AI) and other elements enabling greater adoption of decentralized clinical trials (DCTs) were part of the clinical research conversation before COVID-19, their adoption skyrocketed as quarantine took hold. Get in-the-moment insight on how these changes will shape the future of clinical trials from Raconteur, including comments from our own Graham Belgrave, Senior Vice President, Head of Global Medical & Regulatory Affairs and Managing Director, Europe.
Interested in more of Graham’s perspectives on the pharmaceutical industry? Check out pharmaphorum’s 12 Questions With… spotlight for additional wisdom from this in-house expert.
Exceptional Strategies for Decentralized Trials
Don’t be intimidated by the increased shift to decentralized and hybrid clinical trials. Advanced Clinical supports partners around the world with customized, end-to-end solutions based on four key considerations:
- Trial dependent flexibility
- Global feasibility
- Investigative site engagement
- Patient and caregiver focus
See how our dedicated services help you succeed on our Hybrid & Decentralized Trials page.
Find even more insight in our Optimised Clinical Research Through Decentralised Trials article.
